Sagility India Limited, incorporated in July 2021, is a prominent healthcare-focused technology-enabled solutions and services provider. The company primarily serves U.S.-based clients within the payer and provider segments, operating as a pure-play healthcare BPM (Business Process Management) firm. Sagility leverages deep domain expertise in the American healthcare sector to deliver operational excellence, enhance client experience, and improve health outcomes.
Headquartered in Bangalore, Sagility exclusively caters to US customers and held a 1.23% market share of the U.S. healthcare outsourcing market as of 2023.
Sagility's comprehensive service portfolio addresses distinct aspects of the healthcare ecosystem:
- Payers Segment: Serves health insurance companies, providing critical services such as claims processing, payment integrity, and clinical management to support financing and reimbursement of healthcare services.
- Providers Segment: Focuses on hospitals, physicians, and diagnostic centers, offering robust revenue cycle management (RCM) services, including insurance verification, billing, and accounts receivable follow-up.
The company's client base has expanded significantly, growing from 44 active client groups in FY24 to 75 in FY25. Gross new client additions more than doubled year-over-year to 38. This growth has also led to improved revenue diversification, with the top 5 clients contributing 77.9% of revenue in FY25, a reduction from 79.2% in FY24.
Sagility India demonstrated exceptional financial performance in Q4 FY25:
- Consolidated Net Profit: Skyrocketed by 127.7% to ₹182.6 crore (compared to ₹80.2 crore in Q4 FY24).
- Revenue: Increased by 22% to ₹1,568 crore (from ₹1,283 crore in Q4 FY24).
- EBITDA: Rose by 21.5% to ₹373 crore (compared to ₹307 crore in Q4 FY24).
For the full fiscal year FY25:
- Revenue: ₹5,570 crore
- Profit: ₹539 crore
The FY25 results were significantly bolstered by the strategic acquisition of BroadPath, a U.S.-based mid-market healthcare BPM firm. This acquisition was entirely funded through internal accruals and added 1,083 employees, new delivery sites, and mid-market clients to Sagility's portfolio.
Sagility currently operates in 5 countries with 33 delivery sites and a global headcount of 39,409 employees as of March 31, 2025, marking a 12.5% year-over-year increase. The company maintains a strong focus on the healthcare sector while continuously expanding its geographical presence and service capabilities.
As of the latest available data, Sagility India's market capitalization stands at ₹19,394.74 crore, underscoring its significant presence in the healthcare BPM sector. A high promoter holding of 82.4% indicates robust backing from its parent organization.
Sagility is actively pursuing digital transformation initiatives. Increased client adoption of digital and automation solutions is a key driver of profitability. The company continues to invest in AI-driven solutions and consulting-led engagements to enhance its service portfolio and maintain a competitive advantage in the rapidly evolving healthcare outsourcing landscape.
The acquisition of BroadPath has proven to be a strategic move, enhancing Sagility's service capabilities and setting the stage for aggressive cross-selling in FY26. Management has explicitly outlined targeted cross-selling into BroadPath's mid-market client base as a core strategy for the upcoming fiscal year.
The company has demonstrated strong financial management:
- Equity: Increased to ₹8,336.1 crore as of March 31, 2025 (up from ₹6,443.1 crore the previous year).
- Net Debt: Reduced to ₹1,043.2 crore (from ₹2,167.8 crore), with the Net Debt/EBITDA ratio improving to 0.68x.
- Debt Repayment: The company has scheduled ₹249 crore for debt repayment in FY26, highlighting its commitment to maintaining a healthy balance sheet.
Sagility India's stock has traded within a 52-week range of ₹27.02 (low) and ₹56.4 (high). The shares have fallen 31.76% from their 52-week high due to a promoter stake sale, with the stock down 19.68% year-to-date, reflecting investor caution.
According to analyst coverage, Sagility India has a target price of ₹58.33, representing a potential upside of 40.79% compared to recent price levels, based on recommendations from 6 analysts. Analysts forecast the company to achieve a revenue CAGR of 12% and a profit CAGR of 40% between FY25 and FY27.
Beyond its financial achievements, Sagility has garnered recognition for its commitment to ESG (Environmental, Social, and Governance) initiatives. The Science Based Targets initiative (SBTi) has validated the company's climate targets. Furthermore, Sagility was awarded "Best Organization for Women 2025" by ET Now and recognized as a "Major Contender" in Everest Group's PEAK Matrix® assessments.
Sagility India's strategic focus on deep domain expertise, operational excellence, and technology-led transformation positions it strongly for sustained growth in the expanding U.S. healthcare outsourcing market. With robust financial performance, a diversified client base, and an expanding global footprint, Sagility India stands as a significant player in the healthcare BPM sector.
